Ascendiant Capital Markets Estimates Synergy CHC Q3 Earnings

Synergy CHC Corp. (NASDAQ:SNYR) – Analysts at Ascendiant Capital Markets dropped their Q3 2026 earnings estimates for Synergy CHC in a report released on Tuesday, June 9th. Ascendiant Capital Markets analyst E. Woo now anticipates that the company will earn $0.01 per share for the quarter, down from their prior forecast of $0.05. Ascendiant Capital Markets currently has a “Buy” rating and a $5.50 target price on the stock. The consensus estimate for Synergy CHC’s current full-year earnings is $0.13 per share. Ascendiant Capital Markets also issued estimates for Synergy CHC’s Q4 2026 earnings at ($0.01) EPS, Q1 2027 earnings at $0.01 EPS, Q2 2027 earnings at $0.04 EPS, Q3 2027 earnings at $0.05 EPS and FY2027 earnings at $0.15 EPS.

Synergy CHC (NASDAQ:SNYR) last announced its earnings results on Thursday, May 14th. The company reported ($0.23) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.03 by ($0.26). The company had revenue of $5.49 million during the quarter. Synergy CHC had a negative net margin of 60.02% and a negative return on equity of 19.51%.

Separately, Weiss Ratings cut shares of Synergy CHC from a “hold (c-)” rating to a “sell (d-)” rating in a report on Friday, April 10th. Two investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $6.25.

Synergy CHC Price Performance

Shares of SNYR stock opened at $0.20 on Friday. The firm’s 50-day moving average is $0.40 and its two-hundred day moving average is $1.23. Synergy CHC has a 12 month low of $0.19 and a 12 month high of $4.00. The company has a market capitalization of $3.05 million, a PE ratio of -0.14 and a beta of -0.27.

Hedge Funds Weigh In On Synergy CHC

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Heartland Advisors Inc. acquired a new position in shares of Synergy CHC during the 3rd quarter worth $1,342,000. Geode Capital Management LLC lifted its position in shares of Synergy CHC by 29.9% during the 4th quarter. Geode Capital Management LLC now owns 36,038 shares of the company’s stock valued at $67,000 after acquiring an additional 8,288 shares during the period. XTX Topco Ltd purchased a new stake in shares of Synergy CHC during the 2nd quarter worth approximately $57,000. DRW Securities LLC purchased a new stake in shares of Synergy CHC during the 4th quarter worth approximately $36,000. Finally, Virtu Financial LLC purchased a new stake in shares of Synergy CHC during the 3rd quarter worth approximately $38,000.

Synergy CHC Company Profile

Synergy CHC Corp. engages in the marketing and distribution of branded health and wellness products. The company was founded on December 29, 2010 and is headquartered in Westbrook, ME.